Skip to content

+8000 Courses & Books

Secure Payment

24/7 Support

+8000 Courses & Books

Secure Payment

24/7 Support

+8000 Courses & Books

Secure Payment

24/7 Support

+8000 Courses & Books

Secure Payment

24/7 Support

+8000 Courses & Books

Secure Payment

24/7 Support

+8000 Courses & Books

Secure Payment

24/7 Support

+8000 Courses & Books

Secure Payment

24/7 Support

+8000 Courses & Books

Secure Payment

24/7 Support

+8000 Courses & Books

Secure Payment

24/7 Support

+8000 Courses & Books

Secure Payment

24/7 Support

+8000 Courses & Books

Secure Payment

24/7 Support

+8000 Courses & Books

Secure Payment

24/7 Support

Skip to product information

USCAP 2025 Contemporary Issues in Breast Pathology

USCAP 2025 Contemporary Issues in Breast Pathology

Regular price $65.00 USD
Regular price $65.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
USCAP 2025 Contemporary Issues in Breast Pathology

USCAP 2025 Contemporary Issues in Breast Pathology

Regular price $65.00
Regular price $65.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details
    Original release date: July 28, 2025

    Course Description
    USCAP 2025 Contemporary Issues in Breast Pathology This course will provide a comprehensive review and update of the pathologic diagnosis and clinical significance of benign, in situ and malignant lesions of the breast identified in surgical specimens and core needle biopsies. The most current adjunctive immunohistochemical and molecular studies to assist in the diagnosis and classification of benign and malignant breast lesions and to guide patient management will be emphasized.

    Target AudiencePracticing academic and community pathologists, and pathologists-in-training

    Learning ObjectivesUpon completion of this educational activity, learners will be able to:
    • Describe the diagnostic criteria and clinical significance of a variety of benign, in situ and malignant breast lesions encountered in surgical specimens and core needle biopsies
    • Discuss differential diagnostic problems in breast pathology and the uses and limitations of ancillary immunohistochemical and molecular tests in arriving at the correct diagnosis
    • Discuss prognostic and predictive assays in patients with breast cancer
    • Intraductal Proliferative Lesions – Ashley Cimino-Mathews, MD


      Section: 1 Presentation 1 Document

      Update on Classification and Management of LCIS – Stuart Schnitt, MD


      Section: 1 Presentation 1 Document

      Contemporary Issues in Breast Core Needle Biopsies – Laura Collins, MD


      Section: 1 Presentation 1 Document

      Digital Slides: Small Glandular Proliferations – Laura Collins, MD


      Section: 1 Presentation 1 Document

      Digital Slides: Atypical Intraductal Proliferations – Cecily Quinn, MD, FRCPath


      Section: 1 Presentation 1 Document

      Inflammatory and Reactive Lesions – Cecily Quinn, MD, FRCPath


      Section: 1 Presentation 1 Document

      Papillary Proliferations – Edi Brogi, MD, PhD


      Section: 1 Presentation 1 Document

      Challenging Fibroepithelial Lesions – Puay Hoon Tan, MD


      Section: 1 Presentation 1 Document

      Apocrine Proliferations – Cecily Quinn, MD, FRCPath


      Section: 1 Presentation 1 Document

      Digital Slides: Fibroepithelial lesions – Puay Hoon Tan, MD


      Section: 1 Presentation 2 Documents

      Spindle Cell Lesions – Cecily Quinn, MD, FRCPath


      Section: 1 Presentation 1 Document

      Vascular Lesions – Gregory Bean, MD, PhD


      Section: 1 Presentation 1 Document
    • Applications of Molecular Testing in Breast Cancer – Ashley Cimino-Mathews, MD


      Section: 1 Presentation 1 Document 1 Certificate 1 Survey
    • Classic Triple Negative Breast Cancers, TILS and the Immune Microenvironment – Ashley Cimino-Mathews, MD


      Section: 1 Presentation 1 Document
    • Special Type Triple Negative Breast Cancers – Laura Collins, MD


      Section: 1 Presentation 1 Document
    • HER2 Low and ER Low Breast Cancers – Stuart Schnitt, MD


      Section: 1 Presentation 1 Document
    • Pathologic Evaluation of Specimens After Neoadjuvant Therapy – Gregory Bean, MD, PhD


      Section: 1 Presentation 1 Document
    • Digital Slides: Spindle Cell and Vascular Lesions – Gregory Bean, MD, PhD


      Section: 1 Presentation 2 Documents
    • Digital Slides: Triple Negative Breast Neoplasms – Stuart Schnitt, MD


      Section: 1 Presentation 1 Document
    • Mucinous and Neuroendocrine Lesions – Puay Hoon Tan, MD


      Section: 1 Presentation 1 Document
    • Specimen Handling and Margin Evaluation – Laura Collins, MD


      Section: 1 Presentation 1 Document
    • Epithelial-Myoepithelial Proliferations – Puay Hoon Tan, MD


      Section: 1 Presentation 1 Document
    • Uncommon Clinical Scenarios – Edi Brogi, MD, PhD


      Section: 1 Presentation 1 Document
    • Digital Slides: Mucinous Lesions and ER+ Breast Cancers – Ashley Cimino-Mathews, MD


      Section: 1 Presentation 1 Document
    • Digital Slides: Unusual Breast Lesions – Edi Brogi, MD, PhD


      Section: 1 Presentation 1 Document
    • Uncommon Types of Invasive Breast Cancers – Gregory Bean, MD, PhD


      Section: 1 Presentation 1 Document
    • Contemporary Lymph Node Evaluation – Edi Brogi, MD, PhD


      Section: 1 Presentation 1 Document
    • Applications of AI to Breast Pathology – Stuart Schnitt, MD


      Section: 1 Presentation 1 Document
    • FREE SECTION: Panel Discussion and Q&A


      Section: 8 Presentations